| NDC Code: |
58468-0180 |
| Proprietary Name: |
Leukine |
| Suffix: |
|
| Non-Proprietary Name: |
sargramostim |
| Dosage Form: |
INJECTION, POWDER, FOR SOLUTION |
| Method: |
INTRAVENOUS; SUBCUTANEOUS |
| Original Marketing Date: |
15-03-2010 |
| End of Marketing: |
30-06-2016 |
| Category Name: |
BLA |
| Application Number: |
BLA103362 |
| Labeler: |
GENZYME CORPORATION |
| Substance Name: |
SARGRAMOSTIM |
| Active Numerator Strength: |
250 |
| Active Ingredient Unit: |
ug/mL |
| Pharm Classes: |
Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
| DEA Schedule: |
|
